Caplight Directory>Companies>NexCure, Inc.-preview>Nexcure


NexCure, Inc.

NexCure, Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://nexcure.com/

Last Round

Series A

Mar 5, 2026

Est. Valuation

$985.7M

Total Funding Raised

$329M

Company Overview

NexCure, Inc. is a healthcare company that partners with health systems to build and operate outpatient treatment centers for CAR-T and other advanced therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCimmuno-oncologycancer therapeuticsclinical stage biotechdrug discovery platformbiotech licensingnovel drug targetstumor microenvironmentsolid tumor therapymonoclonal antibodyimmunomedicinefusion proteinacute myeloid leukemiaB7-H4 inhibitorAlzheimer's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NexCure, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NexCure, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 5, 2026
Private PlacementNov 17, 2025
Follow-on OfferingNov 19, 2019
IPO AnnouncedMay 8, 2019
Series BNov 13, 2018
Series A
Jan 6, 2016
View all Funding Rounds

NexCure, Inc. Investors

Notable investors and investment history

InvestorRounds
Bay City CapitalSeries B
Surveyor CapitalSeries B
RA Capital ManagementSeries A
Hillhouse InvestmentSeries B
Taiho VenturesSeries B
OrbiMedSeries A, Series B
Ikarian CapitalPrivate Placement
View all Investors

NexCure, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NexCure, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NexCure, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2026
Last FundingMar 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.